Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Intangibles: 2022-2025

Historic Change in Intangibles for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to $26,103.

  • Sunshine Biopharma's Change in Intangibles fell 71.79% to $26,103 in Q3 2025 from the same period last year, while for Sep 2025 it was $615,987, marking a year-over-year decrease of 39.20%. This contributed to the annual value of $322,258 for FY2024, which is 54.34% down from last year.
  • Per Sunshine Biopharma's latest filing, its Change in Intangibles stood at $26,103 for Q3 2025, which was down 93.31% from $390,187 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Change in Intangibles ranged from a high of $686,044 in Q4 2023 and a low of -$402,296 during Q2 2024.
  • Moreover, its 3-year median value for Change in Intangibles was $92,519 (2024), whereas its average is $149,902.
  • The largest annual percentage gain for Sunshine Biopharma's Change in Intangibles in the last 5 years was 4,185.27% (2024), contrasted with its biggest fall of 150.26% (2024).
  • Quarterly analysis of 4 years shows Sunshine Biopharma's Change in Intangibles stood at $111,015 in 2022, then skyrocketed by 517.97% to $686,044 in 2023, then crashed by 100.70% to -$4,830 in 2024, then crashed by 71.79% to $26,103 in 2025.
  • Its Change in Intangibles stands at $26,103 for Q3 2025, versus $390,187 for Q2 2025 and $204,527 for Q1 2025.